Company Filing History:
Years Active: 2019
Title: Mathew Hardy: Innovator in Modified von Willebrand Factor
Introduction
Mathew Hardy is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of modified polypeptides that have important applications in medicine.
Latest Patents
Mathew Hardy holds a patent for a modified von Willebrand Factor. This invention provides a modified polypeptide that binds Factor VIII. The modified polypeptide comprises a sequence as shown in SEQ ID NO:3, which includes at least a modification at position 1 or 3. This modification allows the polypeptide to bind to Factor VIII with an off rate at least five-fold lower than a reference polypeptide that comprises the unmodified SEQ ID NO:3. He has 1 patent to his name.
Career Highlights
Mathew Hardy is currently employed at CSL Behring Lengnau AG, a company known for its innovative therapies in the field of biotechnology. His work focuses on enhancing the efficacy of treatments related to blood disorders.
Collaborations
Some of Mathew's coworkers include Michael Wilson and Steve Dower, who contribute to the collaborative environment at CSL Behring Lengnau AG.
Conclusion
Mathew Hardy's work in the field of modified von Willebrand Factor showcases his innovative spirit and dedication to advancing medical science. His contributions are vital for the development of effective therapies for patients with blood disorders.